Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells.

Veenhuis RT, Freeman ZT, Korleski J, Cohen LK, Massaccesi G, Tomasi A, Boesch AW, Ackerman ME, Margolick JB, Blankson JN, Chattergoon MA, Cox AL.

J Clin Invest. 2017 Dec 1;127(12):4352-4364. doi: 10.1172/JCI95375. Epub 2017 Oct 30.

2.

Why a radical overhaul of dentistry is needed.

Cohen LK, Dahlen G, Escobar A, Fejerskov O, Johnson NW, Manji F.

Indian J Dent Res. 2017 Sep-Oct;28(5):471-474. doi: 10.4103/ijdr.IJDR_449_17. No abstract available.

3.

Effects of neural differentiation maturity status of human induced pluripotent stem cells prior to grafting in a subcortical ischemic stroke model.

Jensen MB, Jager LD, Cohen LK, Kwok SS, Kwon JM, Hall CA, Heilingoetter C.

Neurol Psychiatry Brain Res. 2016 Dec;22(3-4):178-182. doi: 10.1016/j.npbr.2016.02.001. Epub 2016 Apr 6.

4.
5.
6.

Global supply of health professionals.

Benzian H, Cohen LK, Wong TC.

N Engl J Med. 2014 Jun 5;370(23):2246-7. doi: 10.1056/NEJMc1404326. No abstract available.

PMID:
24897099
7.

Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance.

Karaba AH, Cohen LK, Glaubach T, Kopp SJ, Reichek JL, Yoon HH, Zheng XT, Muller WJ.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):116-24. doi: 10.1093/jpids/pis009. Epub 2012 May 3.

8.

Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation.

Kopp SJ, Karaba AH, Cohen LK, Banisadr G, Miller RJ, Muller WJ.

J Virol. 2013 Jan;87(1):474-81. doi: 10.1128/JVI.01849-12. Epub 2012 Oct 24.

9.

Students passionate for global health--dental schools beginning to respond.

Cohen LK, Valachovic RW.

Compend Contin Educ Dent. 2012 Jul-Aug;33(7):470-1. No abstract available.

PMID:
22908595
10.

The UN High-level Meeting on Prevention and Control of Non-communicable Diseases and its significance for oral health worldwide.

Benzian H, Bergman M, Cohen LK, Hobdell M, Mackay J.

J Public Health Dent. 2012 Spring;72(2):91-3. doi: 10.1111/j.1752-7325.2012.00334.x. Epub 2012 May 3. No abstract available.

PMID:
22551307
11.

UN summit: stepping up efforts to address oral diseases.

Cohen LK, Benzian H, Bergman M.

Compend Contin Educ Dent. 2012 Apr;33(4):234-5. No abstract available.

PMID:
22536656
12.

Injected Versus Oral Cyclosporine for Human Neural Progenitor Grafting in Rats.

Jensen MB, Krishnaney-Davison R, Cohen LK, Zhang SC.

J Stem Cell Res Ther. 2012 Apr 20;Suppl 10:003.

13.

Live.Learn.Laugh.: a unique global public-private partnership to improve oral health.

Cohen LK.

Int Dent J. 2011 Aug;61 Suppl 2:1. doi: 10.1111/j.1875-595X.2011.00039.x. No abstract available.

PMID:
21770934
14.

Transferring knowledge on patient safety.

Cohen LK.

Compend Contin Educ Dent. 2011 Jun;32(5):10-1. No abstract available.

PMID:
21755891
15.

Oral health of Haiti (OHOH): a year later.

Estupinan-Day S, Cohen LK.

Compend Contin Educ Dent. 2011 Mar;32(2):10-2. No abstract available.

PMID:
21473295
16.

Attributes of an ideal oral health care system.

Tomar SL, Cohen LK.

J Public Health Dent. 2010 Jun;70 Suppl 1:S6-14. doi: 10.1111/j.1752-7325.2010.00172.x.

PMID:
20545832
17.

Caries-free communities: is this for real?

Cohen LK, Estupiñán-Day S.

Compend Contin Educ Dent. 2009 Oct;30(8):484-5. No abstract available.

PMID:
19824563
18.

Global health research for America's vital interest.

Cohen LK.

J Am Dent Assoc. 2007 Nov;138(11):1446-8. No abstract available.

PMID:
17974640
19.

Addressing global health research in the national interest.

Cohen LK.

J Public Health Dent. 2007 Spring;67(2):67-8. No abstract available.

PMID:
17557675
20.

Women leading change: the case for oral health.

Cohen LK.

J Dent Educ. 2004 Jul;68(7 Suppl):60-2. No abstract available.

21.

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.

Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF.

Cancer Chemother Pharmacol. 2000;46 Suppl:S67-72.

PMID:
10950151
22.

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG.

Cancer Res. 1999 Oct 15;59(20):5160-8.

23.

Opportunities for international research collaborations: mechanisms for advancement.

Cohen LK.

J Dent Educ. 1999 Mar;63(3):263-7. No abstract available.

PMID:
10225020
24.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

Soiffer R, Lynch T, Mihm M, Jung K, Rhuda C, Schmollinger JC, Hodi FS, Liebster L, Lam P, Mentzer S, Singer S, Tanabe KK, Cosimi AB, Duda R, Sober A, Bhan A, Daley J, Neuberg D, Parry G, Rokovich J, Richards L, Drayer J, Berns A, Clift S, Cohen LK, Mulligan RC, Dranoff G.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13141-6.

25.

Regulation of gene expression in vivo following transduction by two separate rAAV vectors.

Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M, Donahue BA, Cohen LK, Mandel RJ, Danos O, Snyder RO.

Nat Biotechnol. 1998 Aug;16(8):757-61.

PMID:
9702775
27.

Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents.

Brauker J, Frost GH, Dwarki V, Nijjar T, Chin R, Carr-Brendel V, Jasunas C, Hodgett D, Stone W, Cohen LK, Johnson RC.

Hum Gene Ther. 1998 Apr 10;9(6):879-88.

PMID:
9581910
28.

Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice.

Snyder RO, Spratt SK, Lagarde C, Bohl D, Kaspar B, Sloan B, Cohen LK, Danos O.

Hum Gene Ther. 1997 Nov 1;8(16):1891-900.

PMID:
9382955
29.

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S, Vowells SJ, Li F, Miller JA, DeCarlo E, Holland SM, Leitman SF, Carter CS, Butz RE, Read EJ, Fleisher TA, Schneiderman RD, Van Epps DE, Spratt SK, Maack CA, Rokovich JA, Cohen LK, Gallin JI.

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12133-8.

30.

Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies.

Davis JL, Witt RM, Gross PR, Hokanson CA, Jungles S, Cohen LK, Danos O, Spratt SK.

Hum Gene Ther. 1997 Aug 10;8(12):1459-67.

PMID:
9287146
31.

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.

Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA.

Nat Genet. 1997 Jul;16(3):270-6.

PMID:
9207793
32.

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH Jr, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF.

Cancer Res. 1997 Apr 15;57(8):1537-46.

33.

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

Ellem KA, O'Rourke MG, Johnson GR, Parry G, Misko IS, Schmidt CW, Parsons PG, Burrows SR, Cross S, Fell A, Li CL, Bell JR, Dubois PJ, Moss DJ, Good MF, Kelso A, Cohen LK, Dranoff G, Mulligan RC.

Cancer Immunol Immunother. 1997 Mar;44(1):10-20.

PMID:
9111579
34.

Women as leaders.

Cohen LK.

Int Dent J. 1996 Dec;46(6):558-64.

PMID:
9023580
35.

Behavior and disease.

Cohen LK.

J Philipp Dent Assoc. 1995 Sep-Nov;47(2):4-10. No abstract available.

PMID:
9462070
36.

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma.

Berns AJ, Clift S, Cohen LK, Donehower RC, Dranoff G, Hauda KM, Jaffee EM, Lazenby AJ, Levitsky HI, Marshall FF, et al.

Hum Gene Ther. 1995 Mar;6(3):347-68. No abstract available.

PMID:
7779918
37.

Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.

Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK.

Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1023-7.

38.

Demonstration of a rational strategy for human prostate cancer gene therapy.

Sanda MG, Ayyagari SR, Jaffee EM, Epstein JI, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW.

J Urol. 1994 Mar;151(3):622-8.

PMID:
8308972
39.

High efficiency gene transfer into primary human tumor explants without cell selection.

Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, Mulligan RC, Pardoll DM.

Cancer Res. 1993 May 15;53(10 Suppl):2221-6.

40.

Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.

Smith KA, Stallard V, Roos JM, Hart C, Cormier N, Cohen LK, Roberts BE, Payne LG.

Vaccine. 1993;11(1):43-53.

PMID:
8427036
41.

Molecular attenuation of vaccinia virus: mutant generation and animal characterization.

Lee MS, Roos JM, McGuigan LC, Smith KA, Cormier N, Cohen LK, Roberts BE, Payne LG.

J Virol. 1992 May;66(5):2617-30.

42.

Formation of lentivirus particles by mammalian cells infected with recombinant fowlpox virus.

Jenkins S, Gritz L, Fedor CH, O'Neill EM, Cohen LK, Panicali DL.

AIDS Res Hum Retroviruses. 1991 Dec;7(12):991-8.

PMID:
1667477
43.
44.

Promoting oral health: guidelines for dental associations.

Cohen LK.

Int Dent J. 1990 Apr;40(2):79-102.

PMID:
2332255
45.

Leadership role of dental associations: oral health promotion.

Cohen LK.

Int Dent J. 1990 Feb;40(1):48-53.

PMID:
2407662
46.

Advances in the epidemiological study of oral-facial diseases.

Burt BA, Albino JE, Carlos JP, Cohen LK, Dubner R, Gershen JA, Greene JC.

Adv Dent Res. 1989 May;3(1):30-41. Review.

PMID:
2690848
47.

Global oral health and opportunities for international collaborations.

Cohen LK.

N Y State Dent J. 1988 Nov;54(9):42-4, 46-8. No abstract available.

PMID:
3186080
48.

Delineation of the viral products of recombination in vaccinia virus-infected cells.

Spyropoulos DD, Roberts BE, Panicali DL, Cohen LK.

J Virol. 1988 Mar;62(3):1046-54.

49.

Societal expectations for oral health: response of the dental care system.

Cohen LK.

J Public Health Dent. 1988 Spring;48(2):82-3. No abstract available.

PMID:
3164405
50.

Converting unmet need for care to effective demand.

Cohen LK.

Int Dent J. 1987 Jun;37(2):114-6.

PMID:
3476462

Supplemental Content

Loading ...
Support Center